ORGANON & CO.
(NYSE: OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

14.580

+0.140 (+0.97%)
Range 14.410 - 14.915   (3.50%)
Open 14.540
Previous Close 14.440
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 7,839,484
Value -
Remark
Delayed prices. Updated at 21 Dec 2024 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis